Gafter U, Malachi T, Barak H, Levi J
Department of Nephrology, Hasharon Hospital, Petah-Tiqva, Israel.
J Lab Clin Med. 1990 Sep;116(3):386-92.
Red blood cell (RBC) calcium, calcium 45 influx, and calcium extrusion as indicated by Ca-stimulated, Mg-dependent adenosine triphosphatase (CaATPase) was determined in patients with chronic renal failure (CRF), patients with CRF receiving continuous ambulatory peritoneal dialysis (CAPD) treatment, and controls. Cell calcium, which in the controls was 5.5 mumol/L of cells, was elevated in patients with CRF--30.6 +/- 6.8 mumol/L of cells (p less than 0.002)--and in patients receiving CAPD-23.6 +/- 6.7 mumol/L of cells (p less than 0.02). Basal CaATPase activity in controls was 850.7 +/- 66.7 nmol inorganic phosphate per milligram of protein per hour. It was suppressed in patients with CRF and patients receiving CAPD: 504.9 +/- 34.4 nmol inorganic phosphate per milligram of protein per hour and 618.2 +/- 47.3 nmol inorganic phosphate per milligram of protein per hour, respectively (p less than 0.01). Calmodulin-stimulated CaATPase revealed a pattern similar to that of CaATPase basal activity. RBC calcium showed an inverse correlation with CaATPase activity (r = -0.935, p less than 0.005) in patients with CRF. Calcium influx was increased in patients with CRF and in patients receiving CAPD: 12.00 +/- 1.34 mumol/L of cells per hour and 13.60 +/- 1.70, respectively, compared with 4.61 +/- 0.39 mumol/L of cells per hour in controls (p less than 0.001). Patients with CRF have elevated RBC calcium levels mainly related to decreased extrusion and to increased influx. CAPD fails to improve substantially these abnormalities. Plasma vanadium levels were markedly elevated in patients undergoing hemodialysis and marginally in patients receiving CAPD.(ABSTRACT TRUNCATED AT 250 WORDS)
测定了慢性肾衰竭(CRF)患者、接受持续性非卧床腹膜透析(CAPD)治疗的CRF患者以及对照组的红细胞(RBC)钙、钙45内流和钙外排情况,后者通过钙刺激的、镁依赖的三磷酸腺苷酶(CaATPase)来表示。对照组细胞钙水平为5.5 μmol/L细胞,CRF患者升高至30.6±6.8 μmol/L细胞(p<0.002),接受CAPD治疗的患者为23.6±6.7 μmol/L细胞(p<0.02)。对照组基础CaATPase活性为每毫克蛋白质每小时850.7±66.7 nmol无机磷酸盐。CRF患者和接受CAPD治疗的患者该活性受到抑制:分别为每毫克蛋白质每小时504.9±34.4 nmol无机磷酸盐和618.2±47.3 nmol无机磷酸盐(p<0.01)。钙调蛋白刺激的CaATPase呈现出与基础CaATPase活性相似的模式。CRF患者中,RBC钙与CaATPase活性呈负相关(r = -0.935,p<0.005)。CRF患者和接受CAPD治疗的患者钙内流增加:分别为每小时12.00±1.34 μmol/L细胞和13.60±1.70 μmol/L细胞,而对照组为每小时4.61±0.39 μmol/L细胞(p<0.001)。CRF患者RBC钙水平升高主要与外排减少和内流增加有关。CAPD未能显著改善这些异常情况。接受血液透析的患者血浆钒水平显著升高,接受CAPD治疗的患者略有升高。(摘要截选至250字)